New publication alert! We predict immunotherapy outcome from gut microbiome using a novel gut-on-a-chip model, providing novel mechanistic insights on immunoregulatory interactions taking place in the gut and impacting systemically.
https://t.co/DqBIb539Wr
We discovered and validate that antigen-tumor mimicry is relevant for response to immunotherapy in melanoma patients, revealing the cross-cohort prognostic value of microbial-based features while providing unprecedented insights on gut microbiota dynamics.
The lab is recruiting (postdoc level) 👇 Join us: we love good science and there is a great team spirit 💫 https://t.co/DXvX6cQUG3; https://t.co/alwHJIilpK
Step up and apply! Great team, fantastic project, a unique opportunity to be part of translational microbiome studies! Apply here or email me directly.
Happy to announce that our recent adipocyte-cancer cell interaction paper is online. We describe a metabolic adaptation of metastatic ovarian tumors to colonize the adipose tissue.
Cracking cancer w/engineered skin commensals. @GalieSerena@Lunezi discuss work of @yerinchen@mfgrp@ScienceMagazine proposing engineering of commensal bacterium of skin #microbiota to cross-present tumor antigens to #Tcells &counteract tumor progression https://t.co/x7DoS3a3Ku
Very happy to announce our latest paper in @GenomeMedicine on the link between microbiome composition and colon cancer properties (molecular and clinical): https://t.co/GTTpl8maYN. A thread
"The person-to-person transmission landscape of the gut and oral microbiomes". Our work on microbiome stransmission published today open-access in @Nature! Fantastic work @MireiaVallesc, the whole @cibiocm group @CIBIO_UniTrento and all the collaborators! https://t.co/EB4TFlIDIh